Amber TX is a platform designed to generate novel, closed-loop, bioelectrical therapies. With a focus on the peripheral vs the central nervous system, Amber targets disease areas where adding closed-loop intelligence may radically improve clinical efficacy and outcomes. Our leading indication is mixed urinary incontinence, an unmet clinical need that affects up to 30% of patients in the total $30bn a year urinary incontinence market.
Location: United Kingdom, England, City of Westminster
Member count: 1-10
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Oxford Sci... | oxfordscie... |